Krystal Biotech, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Krystal Biotech, Inc. on May 30, 2019. The filing reports on the results of the Company's annual meeting of stockholders held on the same date. Krystal Biotech is an emerging growth company incorporated in Delaware, with its common stock trading on the Nasdaq under the symbol KRYS.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes and Voting Results
The primary material event reported is the outcome of two proposals submitted to stockholders at the annual meeting:
- Election of Directors: Two Class II directors were elected to the Board of Directors for a term expiring at the 2022 annual meeting.
- Daniel S. Janney: Received 9,168,055 votes for, 423,184 votes withheld, and 2,396,064 broker non-votes.
- Dino A. Rossi: Received 8,894,263 votes for, 696,976 votes withheld, and 2,396,064 broker non-votes.
- Ratification of Auditors: Stockholders ratified the selection of Mayer Hoffman McCann P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Votes For: 11,968,542
- Votes Against: 8,798
- Abstentions: 9,963
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Confirm the successful election of Daniel S. Janney and Dino A. Rossi to the Board of Directors.
- Verify the ratification of Mayer Hoffman McCann P.C. as the independent auditor for the 2019 fiscal year.
- Note the significant number of broker non-votes (2,396,064) recorded for the director elections, which may indicate shares held in street name where brokers lacked discretionary voting power.
- Review subsequent filings (e.g., 10-Q or 10-K) for financial performance data, as this 8-K contains no financial metrics.